drugset / Trial / NCT06380153
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study was to evaluate the pharmacokinetics of Hemay005 tablets in subjects with mild to moderate renal impairment and normal renal function, and to provide a basis for the formulation of clinical medication regimens for patients with renal impairment.
Timeline
- Start
- 2024-05-07
- Primary completion
- 2025-04-16
- Completion
- 2025-04-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MUFEMILAST | Small molecule | 60 mg | Oral |